Kurtoglu Metin
- SEC CIK
- 0002000284
No open-market purchases or sales filed in the past year.
Current role at each company
- RNAC Cartesian Therapeutics, Inc.Chief Technology Officeras of Jan 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kurtoglu Metin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Kurtoglu MetinChief Technology Officer | SSale | −4.88K | $16.78 | −$81.8K | −7.3%62.3K after | 2 lots |
| Dec 11, 2024 (view filing) | Dec 9-10 | 2 days | Kurtoglu MetinChief Technology Officer | SSale | −13.7K | $25.26 | −$345.1K | −21.1%51.0K after | 3 lots |
| Nov 21, 2024 (view filing) | Nov 19-21 | 2 days | Kurtoglu MetinChief Technology Officer | SSale | −38.7K | $16.78 | −$649.1K | −43.1%51.0K after | 4 lots |
| Nov 18, 2024 (view filing) | Nov 14-18 | 4 days | Kurtoglu MetinChief Technology Officer | SSale | −82.4K | $17.46 | −$1.44M | −61.7%51.0K after | 5 lots |